期刊
CURRENT OPINION IN PHARMACOLOGY
卷 17, 期 -, 页码 71-80出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2014.07.014
关键词
-
资金
- Aimwell Charitable Trust (UK)
- KAMIN (Israel Ministry of Trade and Industry) [49041]
- Israel Science Foundation [699/10]
Eosinophils are innate immune cells and active players in inflammatory responses. Their activation and increased levels in the blood and at specific sites are associated with parasitic infections and several inflammatory conditions, notably allergic diseases in which eosinophils are considered to be damaging cells. Intervention targeting eosinophils is thought to prevent and/or limit irreversible organ damage and other eosinophil-associated disorders like hypereosinophilic syndromes, some cancers and autoimmune diseases. Several eosinophil-targeted therapeutic agents which block specific steps in eosinophil differentiation, migration and activation have recently been developed, showing encouraging results and new insights into their specific role in allergy. Here, we review some potentially effective drug compounds, their drawbacks and future prospective focusing on allergic diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据